Source: GlobalNewswire

Press Release: Schrodinger : Schrödinger and MaRS Innovation Announce the Launch of Bright Angel Therapeutics

Bright Angel Therapeutics to leverage Schrödinger's best-in-class drug discovery platforms to develop novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Ramy Farid's photo - President & CEO of Schrodinger

President & CEO

Ramy Farid

CEO Approval Rating


Schrodinger develops a chemical simulation software that offers drug design and molecular modeling solutions for pharmaceutical and biotechnology companies. Read more